The present invention relates to a dispensing apparatus comprising (i) a liquid solution of bacteria, preferably live and viable bacteria, even more preferably live and viable bacteria having an intact cell membrane, and (ii) a dispensing device. Further, the present invention relates to a use of said dispensing apparatus for sanitising surfaces and/or environments, preferably indoor environments. Furthermore, the present invention relates to an air conditioning system comprising said dispensing apparatus.
Finally, the present invention relates to a method of sanitisation implemented by said dispensing apparatus, or by said air conditioning system.
An air conditioner is a thermal machine designed to lower or raise the temperature in an environment (e.g. in a room or in the passenger compartment of a vehicle) and is therefore one of the possible benefits to combat heat and mugginess or, conversely, cold and humidity.
The operating principle of air conditioners is the so-called “heat pump”: by transferring heat to, or absorbing heat from, a heat exchange fluid contained in a circuit, energy is removed from one side of the circuit to be transferred to another side of the same circuit.
The construction elements of an air conditioning system are: compressor, evaporator, condenser, lamination valve, reversible valve, and air filter.
The compressor creates a pressure difference that allows the circuit (and thus the thermodynamic cycle) to function, as it sucks in and compresses the heat exchange fluid from the evaporator, and pushes this fluid into the condenser. In the condenser, this fluid condenses under pressure, releasing the absorbed heat. After the condenser, the fluid passes through the lamination valve, which is a throttling organ delegated to degrade the pressure energy in friction, and which produces an irreversible expansion of the condensed heat exchange fluid. Fluidically downstream of the lamination valve, the heat exchange fluid flows into the evaporator to restart its cycle. Thus, the heat exchange fluid changes its physical state in the two heat exchangers, i.e. in the evaporator (from a liquid state to a gas state) and in the condenser (from a gas state to a liquid state).
The reversible valve is the construction element delegated to reverse the flow direction of the heat exchange fluid in the circuit, thus allowing heat to be taken from the environment (lowering its temperature), or heat to be introduced into the same environment (raising its temperature).
Finally, the air filter is necessary to clean the air—thermally treated in the air conditioner—from solid particles and suspended microorganisms.
One of the critical issues in air conditioned is system maintenance, and more specifically the cleaning of air filters. These filters are an ideal environment for a colonisation by pathogenic microorganisms, such as bacteria (e.g. of the Legionella genus) and moulds (e.g. of the Penicillium genus), and provide a warm, moist environment that supports their proliferation. Serious human health problems can result from contaminated air filters, as pathogenic micro-organisms—under the forced drive of the air—can pass through ventilation ducts, be released into the environment, settle on surfaces, and be breathed in or come into contact with the eyes.
Especially in workplaces, contamination of air conditioning systems frequently causes cases of “sick building syndrome” (or SBS), a pathological condition that occurs when from 20% to 30% of workers suffer symptoms—such as migraine, drowsiness, nasal obstruction, itching, irritation, conjunctivitis, eye burning and respiratory disorders—but without specific causes or diseases being identified.
The Applicant, after lengthy and intensive research and development activity, has developed a dispensing apparatus, an air conditioning system and a sanitising method capable of providing an adequate response to the existing limitations, inconveniences and problems.
In particular, the present apparatus, system and method are designed to atomise a liquid solution containing bacteria, preferably live and viable bacteria, even more preferably live and viable bacteria having an intact cell membrane, wherein such bacteria remain viable during atomisation of the liquid solution, so as to be able to survive, replicate and colonise the environment and surfaces.
The present invention thus makes it possible to re-establish or achieve a biological balance in the air, in environments, preferably indoor environments and/or on surfaces, thereby drastically reducing the concentration of harmful or pathogenic bacteria and allergens, and helping to create a permanently healthy ecosystem.
Accordingly, it is an object of the present invention a dispensing apparatus comprising a liquid solution of preferably live and viable bacteria, even more preferably live and viable bacteria having intact cell membranes, and a dispensing device, having the characteristics as defined in the accompanying claims.
It is also an object of the present invention a use of said dispensing apparatus for sanitising surfaces and/or environments, having the characteristics as defined in the accompanying claims.
It is also an object of the present invention an air conditioning system comprising said dispensing apparatus, having the characteristics as defined in the accompanying claims.
It is a further object of the present invention a method of sanitising implemented by said dispensing apparatus, or by said air conditioning system, having the characteristics as defined in the accompanying claims.
Preferred embodiments of the present invention will be described herein by way of example, and therefore not limitative, with the aid of the attached drawings, wherein:
Therefore, it is an object of the present invention a dispensing apparatus, marked—in its entirety—with reference number 1 in the attached drawings.
The dispensing apparatus comprises: (a) a liquid solution of probiotic bacteria 2 having intact cell membranes (and therefore viable); and (b) a dispensing device 10.
In the present description, the term “viable” means that a percentage from 90% to 100% of the total probiotic bacteria in the liquid solution, preferably from 95% to 99%, even more preferably from 96% to 98.5%, has an intact cell membrane, and is therefore “living” regardless of its ability to replicate.
Said probiotic bacteria having intact cell membranes are preferably non-spore-forming bacteria.
Preferably, said probiotic bacteria having intact cell membranes are selected from bacteria of the genus Lactobacillus, Bifidobacterium, Streptococcus, Lactococcus, Akkermansia, Intestinimonas, Eubacterium, Faecalibacterium, Neisseria, Roseburia, Cutibacterium, and mixtures thereof; more preferably from bacteria of the genus Lactobacillus, Bifidobacterium, and mixtures thereof Even more preferably, said probiotic bacteria having intact cell membranes are selected from the group comprising or, alternatively, consisting of: Lactobacillus acidophilus, Lactobacillus buchneri, Lactobacillus fermentum, Lactobacillus salivarius subsp. salivarius, Lactobacillus crispatus, Lactobacillus paracasei subsp. paracasei, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus delbrueckii subsp. delbrueckii, Lactobacillus rhamnosus, Lactobacillus pentosus, Lactobacillus fermentum, Lactobacillus brevis, Lactobacillus plantarum, Lactobacillus casei, Lactobacillus reuteri, Lactobacillus johnsonii, Bifidobacterium adolescentis, Bifidobacterium animalis subsp. lactis, Bifidobacterium breve, Bifobacterium catenulatum, Bifobacterium pseudocatenulatum, Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium infantis, Bifidobacterium longum, Akkermansia munichipila, Intestinimonas butyriciproducens, Eubacterium hallii, Faecalobacterium prausnitzii, Neisseria lactamica, Roseburia hominis, Cutibacterium acnes, and mixtures thereof.
Said probiotic bacteria having intact cell membranes are preferably freeze-dried bacteria reconstituted in the liquid solution. Said liquid solution is preferably an aqueous liquid solution of probiotic bacteria 2, more preferably an aqueous liquid solution of sodium chloride.
The aqueous liquid solution of sodium chloride preferably includes, in addition to the probiotic bacteria having intact cell membranes, sodium chloride in an amount from 0.1% to 15% by weight, preferably from 0.2% to 10% by weight, with respect to the total weight of said aqueous liquid solution.
The dispensing device 10 comprises: (i) a reservoir 4 accommodating said liquid solution of probiotic bacteria 2; (ii) a pressurised gas source 6; (iii) a dispensing body (or dispensing gun) 8; and (iv) at least one peristaltic pump 18.
The dispensing device 10 is preferably only partially enclosed in a device casing 34, preferably made of a metal material, more preferably steel, even more preferably stainless steel (e.g. AISI 304).
In this description, the expression “only partially enclosed” means that not all parts of the dispensing device 10 are contained in the device casing 34. By way of example, at least the reservoir 4 and the dispensing body 8 are preferably outside the device casing 34.
The device casing 34 preferably delimits at least two separate casing compartments 36, 38, a first casing compartment 36 (or lower compartment) accommodating the hydraulic parts of the device, and a second casing compartment 38 (or upper compartment) accommodating the electrical parts of the device. The separate casing compartments 36, 38 are preferably closed by at least one opening casing door 64.
Preferably, the dispensing device 10 comprises first temperature detection means 62 for detecting the temperature in the first casing compartment 36 and/or the second casing compartment 38. The first temperature detection means 62 therefore serve to signal any, abnormal changes in temperature in one or both of said compartments 36, 38.
The reservoir 4 has a volume commensurate with the volume of liquid probiotic bacteria solution 2 to be accommodated within it. By way of example, reservoir 4 could have a volume of from 0.5 litres to 200 litres, preferably from 0.6 litres to 2 litres or from 10 litres to 100 litres.
Preferably, the dispensing device 10 comprises stirring means 40 of the liquid probiotic bacteria solution 2 functionally connected to the reservoir 4. The stirring means 40 serve to prevent gradients concentration or deposits from forming within the reservoir.
In the embodiments shown, the stirring means 40 comprise a mechanical stirrer 42 comprising an impeller 44 at least partially immersed—in a rotatable manner—in the liquid solution.
Preferably, the stirring means 40 comprise an insufflation conduit inserted into the liquid solution, configured to introduce a gas (preferably air) into said solution, so as to generate mixing. Preferably, the insufflation conduit has a free end, from which said gas flows out, located at a bottom wall 46 of said reservoir or immersed in said reservoir.
Said reservoir 4 preferably comprises at least one closure element (not illustrated), which overlaps at least partially with an access opening 48 of said reservoir. Said closure element is preferably crossed by openings accommodating the stirring means 40 (i.e. the insufflation conduit or the impeller 44; when provided), a suction conduit 50 of the liquid solution (connected to the peristaltic pump 18) and, optionally, a level detector 52 of said liquid solution.
Reservoir 4, accommodating the liquid solution of probiotic bacteria 2, is preferably a thermostatically controlled reservoir.
The dispensing device 10 therefore preferably comprises (v) refrigeration means 20—only schematised in
Preferably, the dispensing device 10 comprises said refrigeration means 20, second liquid solution temperature detection means, and management and control means 32. The management and control means 32 are functionally connected to the second temperature detection means so as to receive temperature detecting signals, and connected to the refrigeration means 20 so as to send temperature control signals to the latter.
Preferably, the means of management and control 32 are electronic. More preferably, the means of management and control 32 comprise at least one programmable logic controller (PLC).
The pressurised gas source 6 is preferably a source of pressurised air (or compressed air).
The source of pressurised gas 6 could include a pressurised container of said gas, or a compressor (fixed or portable), or a compressor plant.
Preferably, the dispensing device 10 comprises a compressed air control unit 54, fluidically placed downstream of the pressurised gas source 6 and upstream of the dispensing body 8. The compressed air control unit 54 serves to regulate a pressurised gas flow and/or to avoid pressure peaks.
The dispensing body 8 delimits a mixing chamber 12 between the liquid probiotic bacteria solution 2 and the pressurised gas, to give a liquid-gas mixture, and comprises at least one dispensing nozzle 14 of said liquid-gas mixture in a form of an atomised jet 16.
Atomised jet 16 comprises substantially spherical droplets with an average diameter in the range from 100 μm to 300 μm.
The average diameter is measured in a manner known in the art, e.g. suitable methods are by means of PDA (Phase-Doppler anemometer) instrumentation.
Preferably, the dispensing nozzle 14 is a nozzle with a variable nozzle opening, i.e. with a passage cross-section that is adjustable depending on—inter alia—the pressure and flow rate of the pressurised gas feed and the pressure and flow rate of the liquid solution feed.
As an example, an atomised jet 16 comprising substantially spherical droplets with an average diameter in the range from 100 μm to 300 μm can be obtained under the following conditions:
Preferably, the atomised jet 16 has the shape schematised in
The pressure of the pressurised gas exits from the dispensing nozzle is preferably about 2.8 bar and the pressure of the liquid solution exits from the dispensing nozzle is about 2.0 bar.
Preferably, the dispensing nozzle 14 has a conformation characterised by an internal spiral.
Preferably, the dispensing nozzle 14 is removably connected to the dispensing body 8, so that the dispensing nozzle 14 can be replaced according to the passage section required for dispensing the atomised jet 16.
As an example, a dispensing nozzle that can be used in this device or apparatus is an automatic spray nozzle ‘SPEEDY JET’, model APAEV24VCC, manufactured by EUROSPRAY SPRAY AND FILTER TECHNOLOGY, S.L. (Spain; https://www.euspray.com/).
Peristaltic pump 18 is connected to reservoir 4 to feed the liquid solution of probiotic bacteria 2 to said mixing chamber 12.
The use of a peristaltic pump 18 in the present dispensing device 10 was not a random choice as this type of pump made it possible to maintain the cell membranes of the probiotic bacteria intact, and thus preserve the viability of these bacteria, and also to avoid contamination of the liquid solution before dispensing.
Preferably, a compression produced by the peristaltic pump 18 is from 1 atmosphere to 5 atmospheres, preferably from 2 atmospheres to 4 atmospheres.
The peristaltic pump 18 preferably comprises at least one motor unit 56 and at least one rotor unit 58, wherein said rotor is connected to a shaft of the motor unit 56 and comprises a plurality of rollers. By means of a rotation of the rollers, and a translational throttling exerted by said rollers on a flexible portion of the suction conduit 50 (via the peristalsis mechanism), the liquid solution is withdrawn from the reservoir 4 by suction and fed to the mixing chamber 12.
The dispensing device 10 preferably includes, fludically downstream of the peristaltic pump 18, at least one non-return valve 60 of the liquid solution.
The dispensing device 10 preferably comprises: (vi) first intercepting means 22 of the pressurised gas; (vii) first detection means 24, 26 of the pressurised gas feed pressure; (viii) second intercepting means 28′, 28″ of the liquid probiotic bacteria solution 2; (ix) second detection means 30 of the liquid probiotic bacteria solution 2 feed pressure; and (x) management and control means 32, functionally connected to said (ii), (iv), (vi), (vii), (viii), and (ix).
The management and control means 32 are preferably configured to receive detection signals from (vii) and (ix), and to generate and send control signals to (ii), (iv), (vi) and/or (viii) so that said pressurised gas feed pressure and said liquid probiotic bacteria solution 2 feed pressure are each within predefined ranges.
Preferably, the first detection means of pressurised gas feed pressure 24, 26 comprise a low pressure detector 24 and a high pressure detector 26, the latter being separate and independent from the low pressure detector 24.
Preferably, the second intercepting means 28′, 28″ of the liquid probiotic bacteria solution 2 comprise a second proximal intercepting means 28′, fluidically upstream of the peristaltic pump, and a second distal intercepting means 28″, preferably downstream of the peristaltic pump 18 and more preferably upstream of the dispensing body 8.
It is also an object of the present invention a use of said dispensing apparatus 1 for sanitising surfaces and/or environments.
It is also an object of the present invention an air conditioning system comprising said dispensing apparatus 1.
In this system, the atomised jet 16 dispensed by the nozzle 14 is dispensed:
Said air conditioning system preferably includes or, alternatively, consists of a heating, ventilation and air-conditioning (HVAC) system.
It is also an object of the present invention a method of sanitising. Preferably, said method of sanitising is implemented by said dispensing apparatus 1, or by said air conditioning system.
This sanitisation method comprises the following steps:
Preferably, in step (ii), probiotic bacteria having intact cell membranes antagonistically replicate and colonise said environment or surface.
Advantageously, the apparatus of the present invention makes it possible to maintain the probiotic bacteria in the liquid solution viable during the various stages of storage of the probiotic bacteria and the liquid solution, during the atomisation of said solution, until after the dispensing of said solution in atomised form.
Advantageously, the apparatus object to the present invention makes it possible to minimise the stresses to which probiotic bacteria are subjected, namely: thermal stress, contact stress and compression stress.
In particular, the adoption of a peristaltic pump (preferably electronically controlled) made it possible to reduce or eliminate the consequences of the three above-mentioned stresses, through a safe transit for the bacteria, which circulate from the reservoir to the dispensing nozzle avoiding excessive pressures of the liquid solution, without coming into direct contact with any potentially harmful source of deterioration. Advantageously, the dispensing nozzle of the dispensing device of the present invention is able to combine two indispensable requirements: on the one hand, to avoid excessive fragmentation of the liquid solution into too small droplets, as this is a source of stress for the probiotic bacteria and their viability. On the other hand, to avoid atomised drops that are too large, as they are unsuitable for suspension transport by airflow.
Advantageously, within the apparatus object of the present invention the probiotic bacteria are able to maintain their characteristics, including their viability, for a period of time of more than 30 days when suspended or resuspended (i.e. reconstituted) in an aqueous solution (preferably of sodium chloride) at a temperature from 1° C. to 8° C., preferably from 2° C. to 5° C., even more preferably from 3.5° C. to 4.5° C. Advantageously, the use of a peristaltic pump in the device object of the present invention does not lead to any kind of alteration in the vital parameters of the probiotic bacteria or the liquid solution comprising them.
Advantageously, the dispensing nozzle in the device of the present invention substantially preserves the viability of atomised probiotic bacteria which—downstream of dispensing into the environment or onto the surface remain viable at a percentage from 90% to 100%, preferably from 95% to 99%, even more preferably from 96% to 98.5%.
Advantageously, the dispensing nozzle can dispense a liquid solution of probiotic bacteria in an environment in an amount between 2×105 CFU/m3 and 10×106 CFU/m3 or can dispense a liquid solution of probiotic bacteria on a surface in an amount between 102 CFU/m2 and 8×104/m2.
These amounts can be measured by means of the MD8 Airport (Sartorius) air sampler, wherein, starting from a liquid solution of probiotic bacteria in an amount expressed as colony forming units per millilitres (CFU/ml) of liquid solution, it is possible to measure the amount of bacteria dispensed in the form of an atomised jet within a volume expressed in an amount expressed as colony forming units per cubic metre (as m3) of a known volume. Alternatively, using the MD8 Airport (Sartorious) air sampler, starting from a liquid solution of probiotic bacteria in an amount expressed as colony forming units per millilitres (CFU/ml) of liquid solution, it is possible to measure the amount of bacteria dispensed in the form of an atomised jet on a surface expressed in an amount expressed as colony forming units per square metre (as m2) of a known surface.
Advantageously, dispensing apparatus 1 makes it possible to dispense probiotic bacteria in a viable form, in a concentration substantially superimposed on that originally loaded in reservoir 4 of dispensing apparatus 1.
Referring to the above-mentioned embodiments of the apparatus, plant, use and method, a person skilled in the art could make substitutions or modifications to the described characteristics depending on the contingencies. These embodiments are also to be considered within the scope of the invention formalised in the following claims.
Furthermore, it is specified that any embodiment can be implemented independently from the other described embodiments.
The following experimental methodology was used:
The results, expressed as CFU/ml of probiotic bacteria solutions, are reported in Table 1, and show that dispensing apparatus 1 is capable of dispensing probiotic bacteria solutions without any loss of viability compared to the original solution (the percentage variations are well within the limits of experimental variability and do not denote any significant loss of concentration and/or viability of the micro-organisms).
Dispensing apparatus 1 thus permits the dispensing of probiotic bacteria in a viable form, in a concentration superimposed on that originally loaded into reservoir 4 of dispensing apparatus 1 (maximum variation of 8% with respect to the solution introduced into the reservoir);
B. subtilis
B. pumilus
B. megaterium
Considering the results obtained in the preliminary experiment, the concentration of probiotic bacteria was assessed by dispensing a liquid solution of probiotic bacteria 2 in the form of an atomised jet 16 in a 1 m3 volume chamber (either dispensed in the air or on a surface), at different dispensing times.
Table 2 shows the initial concentrations as CFU/ml and the amount of probiotic bacteria in air inside the test chamber as CFU/m3 over a period of operation of dispensing apparatus 1 of 30 seconds, 1 minute, 3 minutes.
Table 3 shows the initial concentrations as CFU/ml and the amount of probiotic bacteria on the surface of sterile plastic Petri dishes inside the test chamber as CFU/m2 over a period of operation of dispensing apparatus 1 of 30 seconds, 1 minute, 3 minutes.
The results of Experiment 2 describe, for example, how starting with a liquid solution containing about 107 CFU/ml, dispensing apparatus 1 is able to dispense a concentration of probiotic bacteria of more than about 106/m3 in the air in 1 minute of dispensing and a concentration of probiotic bacteria of more than 103/m2 on surfaces in 1 minute of dispensing.
B. subtilis
B. pumilus
B. megaterium
B. subtilis
B. pumilus
B. megaterium
Number | Date | Country | Kind |
---|---|---|---|
102021000013319 | May 2021 | IT | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2022/054809 | 5/23/2022 | WO |